Our fruits and vegetables arent as healthy as they once were

Together, edge development, componentisation and simpler tooling should simplifysolution development, decentralising it to the grassroots while making businessstakeholders less reliant on IT. Key Topics Covered: Executive summary Getting power to the people Components and composition Roles and realities Adult supervision still requiredFor more information visit http:// Ovum Laura WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: 353-1-481-1716 Copyright Business Wire 2009. DUBLIN, Ireland(Business Wire)Research and Markets( http://) hasannounced the addition of Decision Resources, Inc.'s new report "It's All Aboutthe Biomarkers: How 2008's Biomarker-Based Partnering Is Driving PersonalizedMedicine" to their offering. Biomarkers-physical characteristics that are objectively evaluated as indicatorsof normal biological processes, pathogenic processes, or pharmacologicalresponses to therapeutic intervention-are high-value-added commodities in drugand diagnostics discovery and development, and biomarker-based strategies arethe key to success in personalized medicine.

In 2008, these strategies weremanifest in a variety of biomarker centered partnerships that involvedpharmaceutical and biotech companies, academic institutions, and governmentagencies and in several significant M&As that we examine in this report. Get the Answers You Need to Shape Your Strategy The push for personalized - medicine is gathering momentum. What are thedriving forces What are the advantages and challenges of the personalizedmedicine paradigm shift for pharma companies For diagnostics companies Forhealthcare in general Biomarker proponents often point to the success of Genentech/Roche/Chugai'sHerceptin to illustrate the value of biomarker-based drug/diagnosticdevelopment. What are the pros and cons of investing inbiomarkers What can companies do to secure their buy-inScope Key trends in biomarker partnering, November 2 - 007 to November 2008:biopharmaceutical and diagnostics company alliances, diagnostics companypartnerships, industry and academia collaborations, and government-sponsored,biomarker-based product development.

Biomarker deal drivers: demand for more-precise diagnostics and safer,more-effective drugs; Lower-cost, lower-risk drug development; growth potentialof the diagnostics market. Expert Commentary: Spectrum Senior Program Manager Lulu Pickering, Ph.D.,offers "Ten Insights on Integrating Personalized Medicine into Pharma BusinessStrategies."Some of the Companies mentioned: 20/20 GeneSystems AB Biodisk Abbott Acrongenomics Affymetrics BioAray Solutions Bio-Manguinhos BioMerieux Bio-Rad Pasteur Caprion Proteomics Castle Biosciences Celera Genomics Chugai Diagnostic Chemicals Exigon Gene Express GeneData Genentech Genomic Health ImClone Immucor Immunicon Innogenetics Inova Diagnostics Inverness Medical Innovations Molecular Vision MTS Health Investors Nanobac Nanogen Nerveda NexGen Diagnostics Regeneron Roche Rosetta Genomics Sanofi -Aventis Sequenom Spectral Diagnostics Stratagene Takeda Veridex Vermillion Vital Diagnostics Vybion Werfen Group WyethFor more information visit http:// and MarketsLaura WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: 353-1-481-1716 Copyright Business Wire 2009. By David Zinczenko, Editor-in-Chief of Mens Health, with Matt GouldingNEW YORK(Business Wire)The authors of the runaway bestsellers Eat This, Not That! and Eat This, NotThat! For Kids! are back with an essential guidebook for navigating the Americansupermarket-EAT THIS, NOT THAT! SUPERMARKET SURVIVAL GUIDE, by David Zinczenko,with Matt Goulding (paperback, $19.95). With obesity rates soaring, food costsclimbing, and family food budgets shrinking, this easy-to-use guide is hittingstores just in time to put shoppers back in control of their health, theirwallets, and their waistlines. Available nationwide in stores today, thisgroundbreaking book reveals hundreds of easy food swaps that can save readersthousands of unwanted calories - without dieting! What many Americans dont know is that food marketers have altered the realityof the weekly trip to the supermarket, making it impossible for shoppers totruly see where the battle lines fall in the fight against fat.

The foodindustry spends $30 billion a year on advertising-nearly half of it pitchingconvenience foods, candy, soda and dessert. Now more than ever, Americans needhelp deciphering misleading food labels and dubious health claims, as the foodwe consume today is considerably different from the food that we ate 20 or 30years ago. And the reasons are as simple as they are sneaky: Weve added extra calories to traditional foods. Today, high-fructose cornsyrup is in an unbelievable array of foods, from breakfast cereals to bread,from ketchup to iced tea Weve been trained to supersize it. The problem is the way we look at food-weshould be looking at cutting down calories, not adding them. Our fruits and vegetables arent as healthy as they once were. We consume 450 calories a day frombeverage, nearly twice as many as 30 years ago, which amount to an extra 23pounds a year! We dont know whats in our food.